Epocrates Coming to an iPhone Near You


By Neil Versel

March 11, 2008 | By popular demand, the Epocrates drug-reference database will soon be among the first batch of non-Apple software available for the iPhone and iPod Touch.

Epocrates, of San Mateo, Calif., participated in the March 6 kickoff event for the public release of the iPhone Software Development Kit, and has already optimized the free version of its online drug reference for the iPhone Web browser — mostly because physicians have been clamoring for it.

“I did not anticipate the amount of physician interest in the iPhone,” Epocrates VP of Marketing Michelle Snyder said at last month’s Healthcare Information and Management Systems Society (HIMSS) conference.

It was only in November that Epocrates issued a BlackBerry version of its software, after years of requests.

Physician interest in Epocrates for the iPhone has been building since last summer, when Stanford University resident in family medicine Steven Chang began circulating a petition on the GeekNUZ blog to demand an iPhone version of Epocrates. Chang delivered copies of a 35-page printout to Apple and Epocrates last September. Typical of the comments on the blog is: “I won’t get an iPhone ’til I can get Epocrates for it. It’s that simple.”

At HIMSS, Epocrates showed the free, advertising-supported Web version of its flagship product, which had been optimized for the iPhone Safari browser, and the company now has an “iPhone Compatibility” link right on its corporate home page.

Now that it has an idea of the demand for an iPhone product, Epocrates is excited. “Developing software for the iPhone is like developing for no other mobile platform,” software engineer Glenn Keighley said at last week’s Apple SDK launch. He called it an “almost desktop-like environment,” due to the greater screen resolution than other personal digital assistants and smartphones.

Indeed, the iPhone version will be the first mobile release of ePocrates software that shows medication images. “We’re also able to use the core animation-backed framework to reinvent and reinnovate some of our existing functionality,” Keighley said.

For example, he said the “Identify Drug” feature, which lets users search for drugs based on color, shape, and other markings when patients don’t remember the name of medications they are on, will include photographs and links to drug monographs on the iPhone and iPod Touch. Epocrates likely will add this process to future releases of PC software, according to Keighley.

The company has not announced a release date for the iPhone software.

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.